Lv3
324 积分 2022-09-10 加入
First trimester ondansetron exposure and risk of structural birth defects
21小时前
待确认
Ondansetron in pregnancy revisited: Assessment and pregnancy labelling by the European Medicines Agency (EMA) & Pharmacovigilance Risk Assessment Committee (PRAC)
21小时前
待确认
Intravenous Ondansetron in Pregnancy and Risk of Congenital Malformations
22小时前
已完结
Intravenous Ondansetron in Pregnancy and Risk of Congenital Malformations
3天前
已完结
Management of women with epilepsy: from preconception to post-partum
4天前
已完结
Safety concerns of maternal antiseizure medications exposure on perinatal and offspring outcomes: a disproportionality analysis based on FDA adverse event reporting system
5天前
已完结
Effect of maternal pregestational diabetes mellitus on congenital heart diseases
6天前
已完结
The state of congenital heart disease
6天前
已完结
Antidepressant Use in Pregnancy and the Risk of Cardiac Defects
6天前
已完结
Benefits and Risks of Antidepressant Drugs During Pregnancy: A Systematic Review of Meta-analyses
7天前
已完结
皖公网安备34019202002308
